Novonesis A S (NVZMF) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Novonesis A/s Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.058 Good morning, ladies and gentlemen, and welcome to the NovoNezis conference call regarding 00:00:05.058 -- 00:00:10.745 the first half 2025 financial result as well as the 2030 growth strategy. 00:00:10.745 -- 00:00:13.589 My name is Yousef, the course call operator. 00:00:13.589 -- 00:00:17.173 I would like to remind you that all participants will be in listen-only mode and that 00:00:17.173 -- 00:00:22.060 this conference will be recorded. The presentations will be followed by a Q&A session. 00:00:22.060 -- 00:00:27.106 You can register for questions at any time by pressing star followed by one on your telephone. 00:00:27.106 -- 00:00:29.847 For operator assistance... 00:00:30.085 -- 00:00:33.991 This conference must not be recorded for publication or for broadcast. 00:00:33.991 -- 00:00:38.077 At this time, it's my pleasure to hand over to Tobias Cornelius Bjoklund. 00:00:38.077 -- 00:00:40.420 Please go ahead. 00:00:40.420 -- 00:00:45.248 Thank you, Operator, and welcome everyone to the Novenesis conference call, both for 00:00:45.248 -- 00:00:50.716 the first half of 2025 and also including the presentation of the 2030 Strategy and Financial 00:00:50.716 -- 00:00:52.192 Targets. 00:00:52.192 -- 00:00:57.201 In this call, our CEO, Esther Baggett, and our CFO, Reiner Lehmann, will review our 00:00:57.201 -- 00:01:01.970 performance for the first half of the year, as well as the outlook for 2025. 00:01:01.970 -- 00:01:07.100 Attending today's call, we have the full executive leadership team, Henrik Jörg Nilsson, 00:01:07.100 -- 00:01:12.357 EVP of Human Health Biosolutions, Andrew Taylor, EVP of Food and Health Biosolutions, 00:01:12.357 -- 00:01:17.361 Tina Feiner, EVP of Planetary Health Biosolutions, Klaus-Krone Fuglsang, Chie...